Inmode Ltd
INMD
View Detailed Chart
14.450USD
+0.010+0.07%
Close 11/07, 16:00（ET）Quotes delayed by 15 min
913.37MMarket Cap
6.11P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.07%
5 Days
-2.17%
1 Month
-9.06%
6 Months
0.00%
Year to Date
-13.47%
1 Year
-25.55%
View Detailed Chart
TradingKey Stock Score of Inmode Ltd
Currency: USD Updated: 2025-11-07Key Insights
The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inmode Ltd's Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Hold
Current Rating
16.800
Target Price
+16.26%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Inmode Ltd Highlights
StrengthsRisks
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Undervalued
The company’s latest PE is 6.01, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 35.31M shares, decreasing 49.11% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.15K shares of this stock.
Inmode Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Inmode Ltd Info
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Ticker SymbolINMD
CompanyInmode Ltd
CEOMr. Moshe Mizrahy
Websitehttps://inmodemd.com/
Related Instruments
+0.76%
+1.13%
+1.15%
+2.23%
-0.34%
+0.98%
+0.62%
+2.39%
+1.13%
+0.43%
+1.07%
+3.17%
+0.17%
-0.74%
+0.28%
+1.15%
+1.30%
-0.49%
+0.66%
-0.42%Popular Symbols
